Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03601897
Brief Title: A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors

First Submitted : July 5, 2018
First Submitted that Met QC Criteria : July 25, 2018
First Posted : July 26, 2018

Last Update Submitted that Met QC Criteria : March 31, 2021
Last Update Posted : April 1, 2021